Prostate Cancer
Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study - Abstract
December 1, 2011
The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer - Abstract
December 1, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial - Abstract
November 30, 2011
Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer - Abstract
November 30, 2011
Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease - Abstract
November 30, 2011
Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland - Abstract
November 30, 2011
Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: A database study - Abstract
November 30, 2011
Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy - Abstract
November 30, 2011
Risk of prostate cancer associated with benign prostate disease: A primary care case-control study - Abstract
November 29, 2011
Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia - Abstract
November 29, 2011
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel - Abstract
November 29, 2011